The global market for mRNA Platform was valued at an estimated US$149.9 Billion in 2023 and is projected to reach US$120.2 Billion by 2030, growing at a CAGR of -3.1% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the mRNA platform market is driven by several factors, including the increasing incidence of infectious diseases, advancements in mRNA technology, and significant investments in biotechnology research. The ongoing threat of pandemics and the need for swift and effective responses have highlighted the importance of mRNA vaccines, spurring demand and investment in this technology.
Technological advancements, such as improved delivery systems and more efficient manufacturing processes, have enhanced the scalability and efficacy of mRNA-based products. Furthermore, substantial investments from both public and private sectors are accelerating research and development activities, leading to new therapeutic applications and expanding the market potential. Regulatory support and expedited approval processes for mRNA vaccines and therapies have also contributed to the rapid growth of this market. These factors collectively underscore the transformative impact of the mRNA platform in modern medicine and its potential to address a wide range of health challenges.
The growth in the mRNA platform market is driven by several factors, including the increasing incidence of infectious diseases, advancements in mRNA technology, and significant investments in biotechnology research. The ongoing threat of pandemics and the need for swift and effective responses have highlighted the importance of mRNA vaccines, spurring demand and investment in this technology.
Technological advancements, such as improved delivery systems and more efficient manufacturing processes, have enhanced the scalability and efficacy of mRNA-based products. Furthermore, substantial investments from both public and private sectors are accelerating research and development activities, leading to new therapeutic applications and expanding the market potential. Regulatory support and expedited approval processes for mRNA vaccines and therapies have also contributed to the rapid growth of this market. These factors collectively underscore the transformative impact of the mRNA platform in modern medicine and its potential to address a wide range of health challenges.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the COVID-19 Vaccine segment, which is expected to reach US$96.5 Billion by 2030 with a CAGR of a -6.1%. The Cancer Vaccine segment is also set to grow at 104.7% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $67.5 Billion in 2023, and China, forecasted to grow at an impressive -0.8% CAGR to reach $13.8 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global mRNA Platform Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global mRNA Platform Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global mRNA Platform Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as AstraZeneca PLC, Asuragen, Inc., Catalent Pharma Solutions, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 96 Featured):
- AstraZeneca PLC
- Asuragen, Inc.
- Catalent Pharma Solutions
- Altogen Labs
- Arcturus Therapeutics, Inc.
- BioNTech AG
- CRISPR Therapeutics
- Aldevron
- AKESOgen, Inc.
- baseclick GmbH
- chimeron bio
- Acuitas Therapeutics
- Accent Therapeutics
- Accanis Biotech F&E GmbH & Co KG
- Avectas
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
REST OF EUROPE
ASIA-PACIFIC
REST OF WORLD
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AstraZeneca PLC
- Asuragen, Inc.
- Catalent Pharma Solutions
- Altogen Labs
- Arcturus Therapeutics, Inc.
- BioNTech AG
- CRISPR Therapeutics
- Aldevron
- AKESOgen, Inc.
- baseclick GmbH
- chimeron bio
- Acuitas Therapeutics
- Accent Therapeutics
- Accanis Biotech F&E GmbH & Co KG
- Avectas
